Related Experiment Videos
[Oxazolidinones and glycopeptides]
1Servicio de Enfermedades Infecciosas. Hospital Universitario Vall Hebron. Barcelona. España. pigrau@hg.vhebron.es
Enfermedades Infecciosas Y Microbiologia Clinica
|February 15, 2003
Summary
This review compares oxazolidinones and glycopeptides, highlighting their distinct mechanisms against gram-positive pathogens. It details their pharmacokinetics, clinical uses, and adverse effects for treating resistant infections.
Area of Science:
- Pharmacology and Microbiology
- Antimicrobial Agents
Context:
- Gram-positive bacterial infections pose significant therapeutic challenges, especially those involving multidrug-resistant organisms.
- Oxazolidinones and glycopeptides are critical antibiotic classes for managing serious gram-positive infections.
Purpose:
- To provide a comprehensive review of oxazolidinones (linezolid) and glycopeptides.
- To compare their chemical structures, pharmacokinetics, antimicrobial spectra, mechanisms of action, resistance, clinical applications, and adverse effects.
Summary:
- Oxazolidinones inhibit protein synthesis, while glycopeptides target cell wall synthesis, both effective against gram-positive pathogens, including resistant strains.
- Linezolid offers excellent oral absorption and flexible administration, with minimal dose adjustment needs in renal or hepatic impairment.
- Glycopeptides have poor oral bioavailability and require renal dose adjustments; vancomycin's main side effect is nephrotoxicity, and teicoplanin can cause fever.
Impact:
- Informs clinical decision-making for selecting appropriate antibiotics based on pathogen susceptibility and patient factors.
- Highlights linezolid's utility in treating glycopeptide-resistant enterococcal infections.
- Provides essential information on managing potential adverse effects associated with these antimicrobial agents.